StonvexLoading…
StonvexStonvexStonvexCore line items from CB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $59.40B | $55.75B | $49.73B | $43.10B |
Operating Income | $13.04B | $11.46B | $9.53B | $6.49B |
Net Income | $10.31B | $9.27B | $9.03B | $5.25B |
EPS (Diluted) | $25.68 | $22.70 | $21.80 | $12.39 |
Total Assets | $272.33B | $246.55B | $230.68B | $199.02B |
Total Liabilities | $192.55B | $178.15B | $166.99B | $148.50B |
Cash & Equivalents | $2.47B | $2.55B | $2.62B | $2.01B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 391.10M | 400.70M | 405.27M | 414.59M |